Skip to main content

Table 3 IC50 values of BJAB, OCI-LY3 and SU-DHL-6 cells after 48 h of treatment with increasing concentrations of the c-MYC-inhibitor, LY294002, Rapamycin, PD98059, SB203580 and 2-DG (MTT assay)

From: Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability

  BJAB OCI-LY3 SU-DHL-6
c-MYC-inh (µM) 10.23 6.48 6.67
LY294002 (µM) 10.66 9.67 10.94
Rapamycin (nM) 1021 912 1208
PD98059 (µM) >50 >50 >50
SB203580 (µM) >50 >50 >50
2-DG (mM) 4.65 4.07 2.86